Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cytokinetics Inc CYTK

Healthcare Biotechnology
Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The Company specializes in muscle biology and the mechanics of muscle... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CYTK)

Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan

GlobeNewswire 3 days ago

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024

GlobeNewswire 5 days ago

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024

GlobeNewswire 5 days ago

Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference

GlobeNewswire 9 days ago

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089

GlobeNewswire 10 days ago

Cytokinetics Reports Third Quarter 2024 Financial Results

GlobeNewswire November 6, 2024

Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024

GlobeNewswire November 5, 2024

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 4, 2024

Cytokinetics to Announce Third Quarter Results on November 6, 2024

GlobeNewswire October 23, 2024
View More News ››

Opinion & Analysis (NDAQ:CYTK)

The inflammatory disease marketplace meets the drug pricing controversy: FBR & Co.'s Vernon Bernardino

The Life Sciences Report October 22, 2015
View More Opinion ››

Bullboard Posts (NDAQ:CYTK)

Cytokinetics Announces Upcoming Presentations at the HCMS Sc

Breaking News: $CYTK Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific...
whytestocks - September 19, 2024

CYTK Price Target Alert: $72.00. Issued by Needham

Breaking News: $CYTK CYTK Price Target Alert: $72.00. Issued by Needham2024-05-23 10:00:08 ET Serge Belanger from Needham issued a price...
whytestocks - May 23, 2024

Overweight Recommendation Issued On CYTK By Barclays

Just In: $CYTK Overweight Recommendation Issued On CYTK By Barclays2024-05-23 07:15:08 ET Barclays analyst issues OVERWEIGHT...
whytestocks - May 23, 2024

Cytokinetics to Participate in March Investor Conferences |

NEWS: $CYTK Cytokinetics to Participate in March Investor Conferences | BenzingaSOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE...
whytestocks - March 4, 2024

5 BIOTECH STOCKS WITH MAJOR UPCOMING CATALYSTS

$CYTK $ADGI $PHAT $AGIO $ICPT   Clinical-Stage companies offer an exciting investment opportunity with massive upside potential...
AviseAnalytics - February 8, 2022

Good news

Good news for CYTK and Reldesemtiv. Hopefully a rise in the price next week. What do you think ?
andre171 - June 16, 2018
View more Bullboard ››

Trillion Energy International Inc.

Trillion Energy International Inc.

Trillion Energy International Inc. is a Canada-based oil and gas producing company that strives to maximize shareholder value ...
View More »